openPR Logo
Press release

Hereditary Angioedema - Prevalent Cases, Treatment Trends, Global Therapeutic Market analysis & Sales Forecast

10-23-2017 11:05 AM CET | Health & Medicine

Press release from: Insight Rush

Hereditary Angioedema - Prevalent Cases, Treatment Trends, Global Therapeutic Market analysis & Sales Forecast

Hereditary Angioedema - Prevalent Cases, Treatment Trends, Global Therapeutic Market analysis & Sales Forecast

Insight Rush has released new market intelligence reports that provide an in-depth research about Hereditary Angioedema. It is a disorder that results in recurrent attacks of severe swelling under the skin. This usually affects the arms, legs, face, intestinal tract, and airway.

All market analysis & research reports for Hereditary Angioedema @ https://insightrush.com/search?type=product&q=Hereditary+Angioedema

What is covered in these reports?
These reports give an overview of the disease along with an understanding of diagnosed patterns, patients affected, unmet medical needs, pipeline analysis & assessment, Market Assessment & List of Marketed and Emerging Products, API manufacturers and current developments for Hereditary Angioedema. The research includes market analysis for the study period of 2015-2025 & key differences in Epidemiology patterns in the countries, United States, Germany, France, Italy, Spain, UK, and Japan. It includes detailed historical and forecasted Hereditary Angioedema Global market & Epidemiology trends.

The Epidemiology Forecast includes Coverage of key Hereditary Angioedema Diagnosed & treated Patient Populations and its prevalent or incident cases segmented by age and sex.

The report on Hereditary Angioedema Pipeline Insight provides details about ongoing therapeutic research and development across Hereditary Angioedema, covering all clinical, pre-clinical and discovery stage products.

Key companies in this report include Novartis Pharmaceuticals, BioCryst Pharmaceuticals & others.

A comparative pipeline therapeutics assessment of Hereditary Angioedema by development stage, therapy type, route of administration and molecule type is also covered in this report. It includes information on the dormant and discontinued pipeline projects related to the area as well.

One of the reports by DelveInsight includes details on Key Companies and Funding, Market Drivers, and barriers, Epidemiology and Market Forecast – 2025 for Hereditary Angioedema. This report’s coverage on the market outlook also enables understanding of country-specific revenue and share by analyzing the performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers, and barriers for the Hereditary Angioedema market, as well as treatment algorithm, current treatments & advancements. It includes a Segment level epidemiology and market split for Hereditary Angioedema.

The report on Global API Manufacturers, Marketed & Phase III Drugs provides an overview of the marketed and Phase III products for Hereditary Angioedema. It also includes Information on product description & forecasted sales till 2020 for the marketed products. It provides comprehensive insights on:

• Active Pharmaceutical Manufacturers details for the marketed products by Country & Region.
• Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details
• Emerging Phase III product profiles for Hereditary Angioedema including product description, developmental activities, licensors & collaborators and chemical information.
• Understanding of the emerging Phase III therapies for Hereditary Angioedema

These reports will help in establishing a comprehensive understanding of the pipeline activity across this Hereditary Angioedema to formulate effective R&D strategies. Gather information about the emerging competitors having a potentially lucrative portfolio in this space and create effective counter-strategies to gain competitive advantage. Gain insights about API manufacturers and identify the marketing status and patent details of products to exploit opportunities for generic drug development.

All research reports related information for Hereditary Angioedema @ https://insightrush.com/search?type=product&q=Hereditary+Angioedema

If you have any specific requirement, please request a sample report OR a telephonic conversation with our analysts, to help you purchase the right market research report.

For more details on the content of each report and ordering information, please contact us.

About Insight Rush:

Insight Rush is a platform that connects Decision Makers with Market Research resources, globally. We help Executives and Business owners to make difficult decisions by providing latest market insights and consumer data. Our extensive collection of reports contains sales forecasts, market shares, production data, industry analysis, information on products and services, countries, market size, trends and much more. Visit us at www.insightrush.com

Contact Information:

Pete Campbell
Insight Rush, 500 N Michigan Avenue, #600,
Chicago, Illinois - 60611, United States.

Email: sales@insightrush.com
Phone: +1.617.500.7555

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hereditary Angioedema - Prevalent Cases, Treatment Trends, Global Therapeutic Market analysis & Sales Forecast here

News-ID: 780917 • Views:

More Releases from Insight Rush

Amyotrophic lateral sclerosis (ALS) - Prevalent Cases, Treatment Trends, Global Therapeutic Market analysis & Sales Forecast
Amyotrophic lateral sclerosis (ALS) - Prevalent Cases, Treatment Trends, Global …
Insight Rush has released new market intelligence reports that provide an in-depth research about Amyotrophic lateral sclerosis. This disease causes the death of neurons which control voluntary muscles. Symptoms commonly develop between the ages of 55 and 75. But, this can occur to people of any age. All market analysis & research reports for Amyotrophic lateral sclerosis @ https://insightrush.com/search?type=product&q=Amyotrophic+lateral+sclerosis What is covered in these reports? These reports give an overview of the disease
Peanut Allergy - Prevalent Cases, Treatment Trends, Global Therapeutic Market analysis & Sales Forecast
Peanut Allergy - Prevalent Cases, Treatment Trends, Global Therapeutic Market an …
Insight Rush has released new market intelligence reports that provide an in-depth research about Peanut Allergy. All market analysis & research reports for Peanut Allergy @ https://insightrush.com/search?type=product&q=Peanut+Allergy What is covered in these reports? These reports give an overview of the disease along with an understanding of diagnosed patterns, patients affected, unmet medical needs, pipeline analysis & assessment, Market Assessment & List of Marketed and Emerging Products, API manufacturers and current developments for
Endometriosis - Prevalent Cases, Treatment Trends, Global Therapeutic Market analysis & Sales Forecast
Endometriosis - Prevalent Cases, Treatment Trends, Global Therapeutic Market ana …
Insight Rush has released new market intelligence reports that provide an in-depth research about Endometriosis. Endometriosis is the abnormal growth of endometrial cells outside the uterus. This disease affects millions of women worldwide. Lupron, developed by Abbvie is the top-selling drug of Endometriosis contributing to the majority of the market size. Other top players include Visanne/Dienogest (Bayer Healthcare), Zoladex (AstraZeneca), Synarel (Pfizer) and Depo-SubQ Provera (Pfizer). All market analysis & research reports
Pulmonary Arterial Hypertension - Prevalent Cases, Treatment Trends, Global Therapeutic Market analysis & Sales Forecast
Pulmonary Arterial Hypertension - Prevalent Cases, Treatment Trends, Global Ther …
Insight Rush has released new market intelligence reports that provide an in-depth research about Pulmonary Arterial Hypertension. Patients with this condition suffer from shortness of breath, fast heartbeat, chest pain and tiredness as a result of increased blood pressure in the arteries of the lungs. All market analysis & research reports for Pulmonary Arterial Hypertension @ https://insightrush.com/search?type=product&q=Pulmonary+Arterial+Hypertension What is covered in these reports? These reports give an overview of the disease along

All 5 Releases


More Releases for Hereditary

Hereditary Angioedema Therapeutics Market - Forecast to 2026
As per the research conducted by GME, the Global Hereditary Angioedema Therapeutics Market will grow with a CAGR value of 8.2%. Population growth, as well as lifestyle changes, improved insurance programs, and increased efforts by pharmaceutical and biotechnology companies to develop new products and solutions for the industry, are expected to fuel market revenue for Hereditary Angioedema in the years ahead. Browse 153 Market Data Tables and 113 Figures spread through
Hereditary Testing Market Size – Forecasts to 2026
The results analyzed by GME showed that the Global Hereditary Testing Market will grow with a CAGR value of 7.1 percent, to hit xx billion USD by 2026. During the forecast timeframe, growth is expected to be driven by growing expenditure on R&D activities and the rising incidence of chronic diseases worldwide. The development may be attributed to the advancement of genetic testing services and the growing demand for personalized
Potential Opportunities of Hereditary Angioedema Treatment Market
The global hereditary angioedema treatment market to gain from increasing incidences of genetic mutation. Recently Fortune Business Insights, published a report titled, "Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025." As per the report, the global hereditary angioedema treatment
Hereditary Angioedema Market Global Comprehensive Research 2020
Global Hereditary Angioedema Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Hereditary Angioedema Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes
Hereditary Angioedema Market Current Overview by 2025
flow of blood or lymphatic fluid, continuous accumulation of fluids outside of the blood vessels, results in swelling of tissues in the arms, feet, intestinal tract, face, or airway. Stress or Minor trauma may also trigger an attack, Swelling in the airway can limit breathing and prompt to life-debilitating obstruction of the airway. Around 33% of individuals with this condition faces non-itchy rash called erythema marginatum at the time of
Hereditary Angioedema Market is propelled by rise in hereditary angioedema (HAE) …
Some of the prominent names operating in the global hereditary angioedema market are Pharming Group NV, Shire plc, CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc. As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Read Report Overview: https://www.transparencymarketresearch.com/hereditary-angioedema-market.html Superior Healthcare